Retrospective Study of Ovarian Cancer Patients With Brain Metastasis
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Ovarian cancer, especially epithelial ovarian carcinoma, has the highest mortality rate among the gynecologic malignancies. The majority of patients with epithelial ovarian carcinoma are diagnosed at advanced stage which has the overall survival rates of only 19-30%. As the advance in the managements which prolonged the overall survival, metastatic lesion in rare location such as brain was noted in few patients of ovarian cancer in recent years. In the retrospective study, the investigators will review the medical records of the ovarian cancer patients with brain metastasis in the investigators hospital to investigate the incidence, clinical courses, optimal managements and possible prognostic factors in the rare condition.
| Condition |
|---|
|
Ovarian Cancer Brain Metastases |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Retrospective |
| Official Title: | Retrospective Study of Ovarian Cancer Patients With Brain Metastasis |
| Estimated Enrollment: | 70 |
| Study Start Date: | April 2010 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
The ovarian cancer patient treated at the Department of Obstetrics and Gynecology of the National Taiwan University Hospital were retrospectively collected. The cancer registration database was searched for the patients with ovarian carcinoma who brain metastases were also diagnosed. The medical records of these patients were reviewed with particular attention to the results of histo-pathological and radiologic reports. Patients with other synchronous primary brain tumor were excluded. The initial management of primary tumor, including the surgery and adjuvant chemotherapy, and the clinical courses and disease status, such as remission, recurrence and progression, were all carefully reviewed. The intra-cranial lesions were all diagnosed by imaging studies, including brain computed tomography (CT) and magnetic resonance imaging (MRI) scans. Therapeutic strategies for the metastatic lesions in the brain were also reviewed. All statistical analyses were performed using the SPSS 13.0 statistical software for Windows. P<0.05 was defined as statistical significance. Survival was measured from the time of initial diagnosis of brain metastasis until the date of death or last contact, and was presented by Kaplan-Meier curves.
Eligibility| Ages Eligible for Study: | 25 Years to 80 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
ovarian cancer patients with brain metastasis
Inclusion Criteria:
- Patients with ovarian cancer and brain metastasis
- Patients ovarian cancer from National Taiwan University Hospital
Exclusion Criteria:
- none
Contacts and Locations| Contact: Wen-Fang Cheng, Professor | 886-2-23123456 ext 71964 | wenfangcheng@yahoo.com |
| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan | |
| Contact: Wen-Fang Cheng, Professor 886-2-23123456 ext 71964 wenfangcheng@yahoo.com | |
| Principal Investigator: | Wen-Fang Cheng, Professor | National Taiwan University Hospital |
More Information
No publications provided
| Responsible Party: | Wen-Fang Cheng/Professor, National Taiwan University Hospital |
| ClinicalTrials.gov Identifier: | NCT01258881 History of Changes |
| Other Study ID Numbers: | 201004066R |
| Study First Received: | December 10, 2010 |
| Last Updated: | December 10, 2010 |
| Health Authority: | Taiwan: Department of Health |
Additional relevant MeSH terms:
|
Neoplasm Metastasis Neoplasms, Second Primary Ovarian Neoplasms Brain Neoplasms Neoplastic Processes Neoplasms Pathologic Processes Endocrine Gland Neoplasms Neoplasms by Site Ovarian Diseases Adnexal Diseases |
Genital Diseases, Female Genital Neoplasms, Female Urogenital Neoplasms Endocrine System Diseases Gonadal Disorders Central Nervous System Neoplasms Nervous System Neoplasms Brain Diseases Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013